US 11,864,811 B2
System and method for ablating breast cancer cells with cold plasma
Xiaoqian Cheng, Falls Church, VA (US); Jerome Canady, Lakeland, FL (US); and Warren J Rowe, Hyattsville, MD (US)
Assigned to US Patent Innovations, LLC, Takoma Park, MD (US)
Filed by Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Takoma Park, MD (US)
Filed on Aug. 22, 2019, as Appl. No. 16/547,962.
Claims priority of provisional application 62/721,265, filed on Aug. 22, 2018.
Prior Publication US 2020/0060748 A1, Feb. 27, 2020
Int. Cl. A61B 18/14 (2006.01); A61B 18/04 (2006.01); A61B 18/00 (2006.01)
CPC A61B 18/042 (2013.01) [A61B 2018/00333 (2013.01); A61B 2018/00583 (2013.01); A61B 2018/00589 (2013.01)] 2 Claims
OG exemplary drawing
 
1. A method for performing cold atmospheric plasma therapy to treat cancer in a patient, the method comprising:
sampling a cancerous tumor in the patient;
performing cold atmospheric plasma treatment at a plurality of settings on sampled cancerous tumor cells ex vivo;
storing said settings and results of said ex vivo cold atmospheric plasma treatment in an electronic storage media;
calculating from said stored settings and results with a processor a cell viability reduction rate of each of a plurality of tested samples;
calculating from said calculated cell viability reduction rates with a processor an average cell viability reduction rate;
projecting cold atmospheric plasma dosages to be used in treatment of the cancerous tumor in vivo based upon said calculated average cell viability reduction rate;
surgically removing the tumor from the patient; and
treating the surgical margins of the tumor in the patient with cold atmospheric plasma at the projected dosages.